GO:0006307 DNA alkylation repair: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006307 DNA alkylation repair is the biological process that removes non-physiological alkyl groups from DNA nucleobases, primarily via DNA alkyltransferases and DNA glycosylases.
• Alkylation damage arises from endogenous and exogenous agents such as nitrosamines, temozolomide, and other alkylating chemicals, producing lesions like O6-methylguanine and N7-methylguanine.
• Key repair proteins include MGMT (O6-alkylguanine-DNA alkyltransferase), ALKBH2/ALKBH3 (Fe(II)/2-oxoglutarate-dependent dioxygenases), and base excision repair glycosylases such as MPG and MUTYH.
• Defective alkylation repair drives mutagenesis, cancer predisposition, and resistance to alkylating chemotherapy, making this pathway a major therapeutic target.
• Chromatin regulators such as HELLS modulate single-strand break repair and cellular responses to DNA alkylation damage, linking chromatin dynamics to alkylation repair.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of DNA alkylation repair genes in cancer and other diseases.
Description
DNA alkylation repair (GO:0006307) is a conserved biological process that protects genome integrity by removing non-physiological alkyl groups from DNA nucleobases. Alkylating agents, including nitrosamines and therapeutic alkylators such as temozolomide, covalently modify DNA bases and generate lesions that can mispair during replication and cause mutations or cell death. The repair of these lesions is essential for maintaining genomic stability and for determining cellular sensitivity to alkylating chemotherapy. This article provides a research-grade overview of the ontology term GO:0006307, its molecular players, disease relevance, and experimental strategies for studying it.
DNA alkylation repair At A Glance
| GO ID | GO:0006307 |
|---|---|
| GO term | DNA alkylation repair |
| Ontology | biological_process |
| Synonym | DNA dealkylation involved in DNA repair |
| Major function | Removal of non-physiological alkyl groups from DNA nucleobases, primarily via DNA alkyltransferases and glycosylases |
| Representative enzymes | MGMT, ALKBH2, ALKBH3, MPG, MUTYH |
| Associated damage | O6-methylguanine, N7-methylguanine, N3-methyladenine, and other alkyl adducts |
| Disease relevance | Cancer predisposition, chemotherapy resistance, and mutagenesis |
What Is GO:0006307?
GO:0006307 DNA alkylation repair is defined as the repair of alkylation damage in DNA, for example the removal of a non-physiological alkyl group from a nucleobase. This process is usually mediated by DNA alkyltransferases, which directly reverse the alkyl adduct, and by other enzymes such as DNA glycosylases that initiate base excision repair.
Why Is DNA alkylation repair Important in Cell Biology?
DNA alkylation repair is critical because alkylating agents are both ubiquitous environmental carcinogens and widely used anticancer drugs. The efficiency of this repair pathway determines whether cells survive, mutate, or die after alkylation damage, directly influencing cancer risk and the efficacy of chemotherapy. Understanding GO:0006307 therefore has broad implications for oncology, toxicology, and the development of precision therapies.
• Protects against endogenous and exogenous alkylating agents that cause mutagenesis.
• Determines sensitivity or resistance to alkylating chemotherapy such as temozolomide.
• MGMT promoter methylation is a clinically relevant biomarker in glioblastoma and other cancers.
• ALKBH2 and ALKBH3 are emerging targets in cancer therapy.
• Defects in alkylation repair contribute to cancer predisposition syndromes.
• Chromatin remodeling factors like HELLS influence alkylation damage responses.
• Provides mechanistic insights into base excision repair and direct reversal pathways.
• Guides development of CRISPR models for drug response studies.
What Happens During DNA alkylation repair?
Recognition of alkylation damage
In simple terms: The cell first detects that a DNA base has been chemically modified by an alkyl group.
Alkylation damage introduces non-physiological alkyl groups on nucleobases, such as O6-methylguanine and N7-methylguanine, which distort normal base pairing and are recognized by repair proteins. The type and position of the alkyl adduct determine which repair pathway is engaged.
Direct reversal by DNA alkyltransferases
In simple terms: Some repair proteins simply remove the alkyl group from the damaged base without cutting the DNA.
DNA alkyltransferases, such as MGMT in humans, directly remove alkyl groups from O6-alkylguanine and other positions in a stoichiometric, suicide reaction that restores the original base. This direct reversal is a hallmark of GO:0006307 and is conserved from archaea to humans.
Oxidative dealkylation by ALKBH enzymes
In simple terms: Other enzymes use oxygen and iron to chemically remove the alkyl group.
The ALKBH family of Fe(II)/2-oxoglutarate-dependent dioxygenases, including ALKBH2 and ALKBH3, oxidatively dealkylate lesions such as 1-methyladenine and 3-methylcytosine, restoring the intact base. These enzymes broaden the repertoire of direct dealkylation beyond alkyltransferases.
Base excision repair of alkylated bases
In simple terms: If direct reversal is not possible, the damaged base is cut out and replaced.
DNA glycosylases such as MPG (N-methylpurine DNA glycosylase) and MUTYH initiate base excision repair by removing alkylated bases, leaving an abasic site that is processed by AP endonuclease, polymerase, and ligase activities. This pathway is especially important for N-alkylated purines that are not substrates for direct reversal.
Chromatin and single-strand break responses
In simple terms: The repair process is influenced by how DNA is packaged and by proteins that fix DNA breaks.
Chromatin remodeling factors such as HELLS mediate single-strand break repair and modulate cellular responses to DNA alkylation damage, linking chromatin dynamics to the alkylation repair process. This integration ensures that repair occurs efficiently within the chromatin context.
Key Genes Involved in GO:0006307 DNA alkylation repair
The following genes and proteins are central to DNA alkylation repair (GO:0006307) and are frequently studied in cancer and DNA repair research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MGMT | Direct reversal of O6-alkylguanine adducts | Biomarker for temozolomide response; promoter methylation studies |
| ALKBH2 | Fe(II)/2-oxoglutarate dioxygenase; dealkylates 1-methyladenine and 3-methylcytosine | Target for cancer therapy; knockout models |
| ALKBH3 | Dioxygenase; repairs alkylated bases in ssDNA | Potential therapeutic target in cancer |
| MPG | DNA glycosylase initiating BER of alkylated purines | Mechanistic studies of alkylation repair |
| MUTYH | DNA glycosylase involved in BER | Colorectal cancer predisposition |
| HELLS | Chromatin remodeler mediating SSB repair | Links chromatin to alkylation damage response |
| XRCC1 | Scaffold protein in BER | Functional studies of alkylation repair |
| PARP1 | Poly(ADP-ribose) polymerase in BER | Therapeutic target; inhibitor studies |
| APEX1 | AP endonuclease in BER | Core BER factor |
| POLB | DNA polymerase in BER | Gap filling after alkylation damage |
| LIG3 | DNA ligase in BER | Completion of repair |
| ATR | DNA damage response kinase | Alkylation-induced checkpoint activation |
| ATM | DNA damage response kinase | Response to alkylation damage |
| TP53 | Tumor suppressor; regulates DNA repair | Apoptosis and repair decisions after alkylation |
| BRCA1 | Homologous recombination factor | Cross-talk with alkylation repair |
| BRCA2 | Homologous recombination factor | Cross-talk with alkylation repair |
| FEN1 | Flap endonuclease in BER | Processing of repair intermediates |
How Is DNA alkylation repair Regulated?
DNA alkylation repair is regulated at multiple levels. MGMT expression is epigenetically silenced by promoter methylation in many cancers, affecting alkylation sensitivity. ALKBH2 and ALKBH3 are regulated by hypoxia and other stress signals. The DNA damage response kinases ATM and ATR coordinate cell cycle arrest and repair activation upon alkylation damage. Chromatin remodeling by HELLS influences the efficiency of single-strand break repair and alkylation damage responses.
DNA alkylation repair and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MGMT | Glioblastoma; temozolomide resistance | MGMT knockout or overexpression in glioma cell lines |
| ALKBH2 | Cancer therapy resistance | ALKBH2 knockout in cancer cells |
| MUTYH | Colorectal cancer predisposition | MUTYH knockout organoids |
| HELLS | Chromatin regulation in alkylation response | HELLS knockout cells |
| TP53 | Apoptosis and repair decisions | TP53 point-mutation models |
Cancer and chemotherapy resistance
High MGMT expression confers resistance to temozolomide in glioblastoma and other tumors, while MGMT promoter methylation predicts better response. ALKBH2 and ALKBH3 overexpression also contributes to alkylation resistance, making them therapeutic targets.
Cancer predisposition
Defects in base excision repair glycosylases such as MUTYH cause colorectal cancer predisposition, highlighting the importance of alkylation repair in genome maintenance.
Neurodegeneration and aging
Chronic alkylation damage and impaired repair contribute to neuronal dysfunction and aging, although the exact mechanisms remain under investigation.
From DNA alkylation repair-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MGMT loss sensitize cells to temozolomide? | MGMT knockout cell line |
| Does ALKBH2 mutation affect alkylation repair? | ALKBH2 point-mutation knock-in |
| Can we track MGMT repair activity in real time? | Tagged MGMT knock-in |
| Does overexpression of ALKBH3 increase resistance? | ALKBH3 overexpression |
| What is the role of HELLS in alkylation damage? | HELLS knockout |
| Can we identify synthetic lethal partners? | CRISPR library screening |
How to Study the DNA alkylation repair Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Comet assay | DNA strand breaks | Alkylation damage quantification |
| MGMT activity assay | Direct reversal activity | Drug resistance studies |
| RNA-seq | Gene expression changes | Repair pathway profiling |
| Proteomics | Protein abundance and modifications | Repair complex analysis |
| CRISPR knockout | Gene function loss | Sensitivity screens |
| CRISPR point mutation | Specific variant effects | Clinical variant modeling |
| CRISPR library screen | Genome-wide fitness | Synthetic lethal discovery |
CRISPR knockout and point-mutation models
CRISPR-Cas9 knockout of MGMT, ALKBH2, or ALKBH3 enables loss-of-function studies to assess alkylation sensitivity and repair capacity. Point mutations can mimic clinically observed variants.
Reporter assays and comet assays
Alkylation damage and repair can be measured using comet assays, which detect DNA strand breaks, and by reporter constructs that quantify repair activity.
Transcriptomics and proteomics
RNA-seq and proteomics reveal expression changes in repair genes after alkylation damage and identify regulatory networks.
CRISPR library screening
Genome-wide CRISPR screens identify genes that modulate sensitivity to alkylating agents, uncovering novel repair factors and therapeutic targets.
How CRISPR Can Be Used to Study GO:0006307 DNA alkylation repair
Knockout
CRISPR knockout of DNA alkylation repair genes such as MGMT, ALKBH2, and ALKBH3 is used to determine their contribution to alkylation resistance and genome stability.
Point Mutation
Point mutations can be introduced to model clinical variants or catalytic-dead enzymes, enabling precise structure-function studies of repair proteins.
Knock-in
Tagged knock-in of repair genes allows live-cell imaging and biochemical purification of repair complexes.
Overexpression
Overexpression of MGMT or ALKBH enzymes is used to study gain-of-function effects on alkylation resistance and to validate therapeutic targets.
How EDITGENE Supports DNA alkylation repair Research
Researchers studying DNA alkylation repair-related genes often need to determine whether a candidate gene is causally involved in the repair process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for DNA alkylation repair research.
Frequently Asked Questions About DNA alkylation repair
What is DNA alkylation repair?
DNA alkylation repair (GO:0006307) is the biological process that removes non-physiological alkyl groups from DNA nucleobases, primarily via DNA alkyltransferases and glycosylases.
What genes are involved in DNA alkylation repair?
Key genes include MGMT, ALKBH2, ALKBH3, MPG, MUTYH, and chromatin factors such as HELLS.
How does MGMT repair DNA alkylation?
MGMT directly removes alkyl groups from O6-alkylguanine in a suicide reaction, restoring the original base.
What diseases are linked to defective DNA alkylation repair?
Defects are linked to cancer predisposition, chemotherapy resistance, and potentially neurodegeneration.
What is the role of ALKBH2 in alkylation repair?
ALKBH2 is a Fe(II)/2-oxoglutarate dioxygenase that oxidatively dealkylates lesions such as 1-methyladenine and 3-methylcytosine.
How can CRISPR be used to study DNA alkylation repair?
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of repair gene function and drug response.
What is the clinical significance of MGMT promoter methylation?
MGMT promoter methylation silences the gene and predicts better response to temozolomide in glioblastoma.
What experimental methods are used to study DNA alkylation repair?
Comet assays, MGMT activity assays, RNA-seq, proteomics, and CRISPR screens are commonly used.
What is the difference between direct reversal and base excision repair in alkylation repair?
Direct reversal removes the alkyl group without cutting DNA, while base excision repair excises the damaged base and replaces it.
Why is DNA alkylation repair important for cancer therapy?
It determines tumor cell sensitivity to alkylating agents like temozolomide, influencing treatment outcomes.
Conclusion
DNA alkylation repair (GO:0006307) is a fundamental genome maintenance process with direct implications for cancer biology and chemotherapy. The interplay between direct reversal enzymes, base excision repair, and chromatin regulators determines cellular outcomes after alkylation damage. Continued research using advanced CRISPR models will uncover new therapeutic opportunities and biomarkers.
References
- 1. Peng Y et al.. 2021. DNA alkylation lesion repair: outcomes and implications in cancer chemotherapy.. J Zhejiang Univ Sci B 22(1):47-62 PMID: 33448187
- 2. Yin Y et al.. 2023. Archaeal DNA alkylation repair conducted by DNA glycosylase and methyltransferase.. Appl Microbiol Biotechnol 107(10):3131-3142 PMID: 37036526
- 3. Fahrer J et al.. 2023. DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways.. Int J Mol Sci 24(5) PMID: 36902118
- 4. Soll JM et al.. 2017. Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities.. Trends Biochem Sci 42(3):206-218 PMID: 27816326
- 5. Drabløs F et al.. 2004. Alkylation damage in DNA and RNA--repair mechanisms and medical significance.. DNA Repair (Amst) 3(11):1389-407 PMID: 15380096
- 7. Joseph JT et al.. 2025. The chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage.. Nucleic Acids Res 53(22) PMID: 41297801
